Outcomes of radical prostatectomies and HDR brachytherapy in patients with intermediate and high risk prostate cancer

被引：0
|
作者：
Macek, P.
Stricker, P.
Stevens, M.
Jagavkar, R.
Chalasani, V.
Haynes, A. M.
Matthews, J.
Brenner, P.
Golovsky, D.
Kooner, R.
O'Neill, G.
机构：
[1] Gen Univ Hosp, Prague, Czech Republic
[2] Garvan Inst Med Res, Sydney, NSW, Australia
来源：
BJU INTERNATIONAL | 2006年 / 97卷
关键词：
D O I：
10.1111/j.1464-410X.2006.06085_12.x
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3 / 3
页数：1
相关论文
共 50 条
  • [1] HDR Brachytherapy Monotherapy in patients with Low/Intermediate-risk Prostate Cancer
    Moreno Olmedo, E.
    Nagore, G.
    Suarez Gironzini, V.
    Minguez, C.
    Gomez, E.
    Garcia, A.
    Ciapa, V.
    Marrone, I.
    Lopez, E.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1122 - S1123
  • [2] HDR Brachytherapy Monotherapy in patients with Low/Intermediate-risk Prostate Cancer
    Moreno Olmedo, E.
    Nagore, G.
    Suarez-Gironzini, V.
    Minguez, C.
    Gomez, E.
    Garcia, A.
    Ciapa, V.
    Marrone, I.
    Lopez, E.
    RADIOTHERAPY AND ONCOLOGY, 2021, 158 : S123 - S123
  • [3] HDR brachytherapy as monotherapy for low and intermediate risk prostate cancer
    Gaudet, M.
    Pharand-Charbonneau, M.
    Wright, D.
    Desrosiers, M.
    Haddad, A.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S1188 - S1188
  • [4] Dose escalation with HDR brachytherapy for intermediate- and high-risk prostate cancer
    Chicas-Sett, R.
    Celada, F.
    Burgos, J.
    Farga, D.
    Perez-Calatayud, M.
    Roldan, S.
    Collado, E.
    Ibanez, B.
    Perez-Calatayud, J.
    Tormo, A.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S380 - S381
  • [5] Outcomes of High-Dose Rate (HDR) Brachytherapy in Intermediate- to High-Risk Prostate Cancer Patients with Prior Transurethral Resection of the Prostate (TURP)
    Lin, E. Y.
    Lee, A.
    Demanes, J.
    Kamrava, M.
    Venkat, P. S.
    Hagio, M. A.
    Zaide, L. B.
    Park, S. J.
    Zarate, C.
    Chang, A. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E888 - E888
  • [6] HDR brachytherapy for high-risk prostate cancer
    Lo, TCM
    Bouyounes, BT
    Goodman, N
    Bihrle, W
    Roth, RA
    CANCER JOURNAL, 2001, 7 (06): : 527 - 527
  • [7] HDR MONO-BRACHYTHERAPY FOR LOW AND INTERMEDIATE RISK CANCER OF THE PROSTATE
    Johansson, B.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S214 - S214
  • [8] HDR brachytherapy as a boost for intermediate and high risk prostate cancer: Longterm outcome of 2028 implants
    Kurek, R
    Martin, T
    Buhleier, T
    Dannenberg, T
    Baltas, D
    Zamboglou, N
    Tunn, UW
    JOURNAL OF UROLOGY, 2006, 175 (04): : 314 - 314
  • [9] HDR Brachytherapy boost irradiation in the radiotherapy (RT) of intermediate and high risk localised prostate cancer
    Agoston, P
    Major, T
    Somogyi, A
    Baricza, K
    Szasz, K
    Lövey, J
    Németh, G
    Kasler, M
    Fodor, J
    RADIOTHERAPY AND ONCOLOGY, 2005, 75 : S4 - S5
  • [10] HDR Brachytherapy in the Management of High-Risk Prostate Cancer
    Masson, Susan
    Persad, Raj
    Bahl, Amit
    ADVANCES IN UROLOGY, 2012, 2012
12345